Turning Point Therapeutics (TPTX) stock Forecast for 2022 – 2026

Turning Point Therapeutics (TPTX) stock Forecast for 2022 – 2026

Last update: 05-16-2022, 12:32

Sector: Healthcare

The share price of Turning Point Therapeutics, Inc. (TPTX) now

What analysts predict:: $109.56

52-week high/low: $83.06 / $23.77

50/200 Day Moving Average: $29.01 / $45.89

This figure corresponds to the average price over the previous 50/200 days. For Turning Point Therapeutics stocks, the 50-day moving average is the support level today.

For Turning Point Therapeutics stocks, the 200-day moving average is the resistance level today.

Are you interested in Turning Point Therapeutics, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Turning Point Therapeutics stock price in 2022, 2023, 2024, 2025, 2026. How much will one Turning Point Therapeutics share be worth in 2022 - 2026?

When should I take profit in Turning Point Therapeutics stock? When should I record a loss on Turning Point Therapeutics stock? What are analysts' forecasts for Turning Point Therapeutics stock? What is the future of Turning Point Therapeutics stock?

We forecast Turning Point Therapeutics stock performance using neural networks based on historical data on Turning Point Therapeutics stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Turning Point Therapeutics stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2022, 2023, 2024, 2025 and 2026)

The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Turning Point Therapeutics shares. This happens once a day.




Historical and forecast chart of Turning Point Therapeutics stock

The chart below shows the historical price of Turning Point Therapeutics stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Turning Point Therapeutics stock price can be found in the table below.

Long-term forecasts by years.

Turning Point Therapeutics daily forecast for a month

Date Target Pes. Opt. Vol., %
May 18 31.45 30.81 32.27 4.72
May 19 31.70 30.44 32.65 7.25
May 20 31.36 30.38 31.98 5.26
May 21 31.49 30.09 32.19 6.97
May 22 30.83 30.16 31.44 4.23
May 23 30.03 28.97 31.46 8.58
May 24 30.63 29.60 31.82 7.51
May 25 30.31 29.55 30.88 4.49
May 26 29.37 28.84 30.37 5.32
May 27 28.66 27.36 29.35 7.29
May 28 27.60 27.10 28.46 5.01
May 29 27.45 27.12 27.86 2.73
May 30 29.05 28.37 30.18 6.39
May 31 28.56 27.39 29.19 6.57
Jun 01 28.75 27.88 29.66 6.37
Jun 02 28.25 27.25 29.42 7.96
Jun 03 27.94 27.47 28.66 4.33
Jun 04 27.74 27.11 28.09 3.62
Jun 05 26.54 25.60 27.12 5.91
Jun 06 26.08 25.56 26.63 4.16
Jun 07 26.38 26.03 27.52 5.72
Jun 08 25.90 24.95 26.94 7.97
Jun 09 26.03 25.23 26.89 6.56
Jun 10 27.01 26.22 28.05 6.99
Jun 11 26.72 25.56 27.89 9.09
Jun 12 27.04 26.24 28.19 7.42
Jun 13 25.87 25.05 26.60 6.20
Jun 14 24.46 23.33 24.99 7.11
Jun 15 24.28 23.73 24.97 5.22
Jun 16 23.16 22.47 23.51 4.64

Turning Point Therapeutics Daily Price Targets


Turning Point Therapeutics Stock Forecast 05-18-2022.

Forecast target price for 05-18-2022: $31.45. Negative dynamics for Turning Point Therapeutics shares will prevail with possible volatility of 4.504%.

Pessimistic target level: 30.81

Optimistic target level: 32.27


Turning Point Therapeutics Stock Forecast 05-19-2022.

Forecast target price for 05-19-2022: $31.70. Positive dynamics for Turning Point Therapeutics shares will prevail with possible volatility of 6.757%.

Pessimistic target level: 30.44

Optimistic target level: 32.65


Turning Point Therapeutics Stock Forecast 05-20-2022.

Forecast target price for 05-20-2022: $31.36. Negative dynamics for Turning Point Therapeutics shares will prevail with possible volatility of 5.001%.

Pessimistic target level: 30.38

Optimistic target level: 31.98


Turning Point Therapeutics Stock Forecast 05-21-2022.

Forecast target price for 05-21-2022: $31.49. Positive dynamics for Turning Point Therapeutics shares will prevail with possible volatility of 6.515%.

Pessimistic target level: 30.09

Optimistic target level: 32.19


Turning Point Therapeutics Stock Forecast 05-22-2022.

Forecast target price for 05-22-2022: $30.83. Negative dynamics for Turning Point Therapeutics shares will prevail with possible volatility of 4.059%.

Pessimistic target level: 30.16

Optimistic target level: 31.44


Turning Point Therapeutics Stock Forecast 05-23-2022.

Forecast target price for 05-23-2022: $30.03. Negative dynamics for Turning Point Therapeutics shares will prevail with possible volatility of 7.905%.

Pessimistic target level: 28.97

Optimistic target level: 31.46


TPTX (TPTX) Monthly Stock Prediction for 2022

Month Target Pes. Opt. Vol., %
Jun. 29.43 27.55 31.43 12.36
Jul. 28.84 26.31 32.91 20.06
Aug. 29.92 27.16 34.79 21.95
Sep. 23.74 20.65 27.49 24.88
Oct. 23.58 21.40 27.00 20.75
Nov. 24.93 21.53 26.90 19.98
Dec. 24.10 20.50 27.87 26.45

Turning Point Therapeutics forecast for this year


Turning Point Therapeutics Stock Prediction for Jun 2022

An downtrend is forecast for this month with an optimal target price of $29.427. Pessimistic: $27.55. Optimistic: $31.43


Turning Point Therapeutics Stock Prediction for Jul 2022

An downtrend is forecast for this month with an optimal target price of $28.8443. Pessimistic: $26.31. Optimistic: $32.91


Turning Point Therapeutics Stock Prediction for Aug 2022

An uptrend is forecast for this month with an optimal target price of $29.9231. Pessimistic: $27.16. Optimistic: $34.79


Turning Point Therapeutics Stock Prediction for Sep 2022

An downtrend is forecast for this month with an optimal target price of $23.735. Pessimistic: $20.65. Optimistic: $27.49


Turning Point Therapeutics Stock Prediction for Oct 2022

An downtrend is forecast for this month with an optimal target price of $23.5784. Pessimistic: $21.40. Optimistic: $27.00


Turning Point Therapeutics Stock Prediction for Nov 2022

An uptrend is forecast for this month with an optimal target price of $24.9271. Pessimistic: $21.53. Optimistic: $26.90


Turning Point Therapeutics Stock Prediction for Dec 2022

An downtrend is forecast for this month with an optimal target price of $24.1045. Pessimistic: $20.50. Optimistic: $27.87




Turning Point Therapeutics (TPTX) Monthly Stock Prediction for 2023

Month Target Pes. Opt. Vol., %
Jan 23.42 22.28 25.84 13.76
Feb 22.90 19.42 25.62 24.19
Mar 19.98 18.97 22.26 14.81
Apr 19.49 16.36 21.81 24.97
May 16.28 14.31 17.60 18.72
Jun 16.06 13.41 17.90 25.07
Jul 19.53 17.51 22.58 22.45
Aug 21.85 18.43 24.20 23.83
Sep 21.65 17.84 22.75 21.57
Oct 25.51 23.94 28.04 14.61
Nov 24.78 20.58 28.16 26.91
Dec 24.51 20.57 26.67 22.85

Turning Point Therapeutics (TPTX) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
Jan 20.90 17.63 22.64 22.13
Feb 19.20 16.28 21.98 25.93
Mar 18.52 15.26 21.78 29.93
Apr 14.61 13.42 16.96 20.85
May 15.54 13.73 16.98 19.13
Jun 18.14 15.82 19.82 20.14
Jul 18.22 15.01 20.70 27.49
Aug 19.86 18.68 21.52 13.20
Sep 20.91 18.43 23.26 20.77
Oct 17.74 15.63 18.91 17.34
Nov 17.11 15.27 19.26 20.72
Dec 16.51 13.75 18.07 23.92



Turning Point Therapeutics (TPTX) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 19.96 17.24 21.37 19.32
Feb 20.09 18.81 22.83 17.62
Mar 18.77 17.94 21.29 15.71
Apr 19.63 16.78 23.05 27.18
May 19.29 16.87 20.35 17.10
Jun 18.91 16.49 20.53 19.65
Jul 19.49 17.17 21.46 19.98
Aug 18.46 16.06 20.53 21.76
Sep 18.01 15.56 20.63 24.59
Oct 19.76 17.37 22.54 22.95
Nov 17.89 17.02 21.00 18.93
Dec 16.86 15.31 18.90 19.04

Turning Point Therapeutics (TPTX) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 15.83 14.68 18.61 21.14
Feb 14.29 13.60 16.12 15.61
Mar 14.07 12.84 14.94 14.09
Apr 16.67 15.50 18.88 17.88
May 15.28 13.06 17.94 27.18
Jun 18.20 16.64 20.13 17.31
Jul 18.00 16.86 20.98 19.64
Aug 16.94 14.92 18.72 20.30
Sep 17.20 15.91 19.62 18.90
Oct 15.95 13.88 17.60 21.13
Nov 14.90 14.21 17.39 18.28
Dec 15.48 13.00 16.23 19.93

Turning Point Therapeutics information and performance

Turning Point Therapeutics, Inc., a clinical stage biopharmaceutical company, designs and develops new small molecule targeted cancer therapies. He is developing a suite of tyrosine kinase inhibitors (TKIs) that targets cancer genetic factors in previously TKI-naive and TKI-treated patients.

Turning Point Therapeutics Address

10628 SCIENCE CENTER DRIVE, SUITE 200, SAN DIEGO, CA, US

Market Capitalization: 1 331 055 000 $

Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.

EBITDA: -46 895 000 $

EBITDA is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: None

Price/earnings to growth

DPS: N/A

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: N/A

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -4.802

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A

Quarterly Revenue Growth YOY: -0.982

Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: -

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 11.52

Enterprise Value (EV) /Revenue

EV To EBITDA: -

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 49666300

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A

Percent Insiders: N/A

Percent Institutions: N/A




Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.